Login
Super Investors LORD ABBETT DEVELOPING GROWTH FUND INC

LORD ABBETT DEVELOPING GROWTH FUND INC

Lord Abbett Developing Growth Fund, Inc. · net assets $2.22B · 95 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 96.5% · RA: 2.1% · STIV: 1.5%

Financial position

Total assets
$2.26B
Total liabilities
$35.5M
Net assets
$2.22B
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $40.1M $47.6M $47.9M
Reinvestment $0 $0 $0
Redemptions $65M $58.7M $46M
Net realized gain (non-derivative) $84.6M $93.1M $105M
Net unrealized appreciation (non-derivative) $175M $50.3M $-469M

The three months of the reporting period, as filed; month 3 ends July 31, 2026.

Filing details

Registrant
Lord Abbett Developing Growth Fund, Inc.
Registrant CIK
276914
Registrant LEI
549300HWJ2W28SDTJF85
Series
LORD ABBETT DEVELOPING GROWTH FUND INC
Series ID
S000006834
Series LEI
549300HWJ2W28SDTJF85
SEC file number
811-02871
Address
30 HUDSON STREET, JERSEY CITY, US-NJ, 07302, US
Phone
201-827-2000
Form
NPORT-P
Filed
September 25, 2026
Report period ends
July 31, 2026
Report month ends
July 31, 2026
Accession number
000141036826099985
Holding Value % of net assets
Guardant Health Inc EC $65.6M 2.95%
Navan Inc EC $52.8M 2.38%
Fixed Income Clearing Corp. RA $46.9M 2.11%
Jfrog Ltd EC $44.3M 1.99%
Digitalocean Holdings Inc EC $43.2M 1.94%
Cogent Biosciences Inc EC $41.2M 1.85%
Ies Holdings Inc EC $40.5M 1.82%
Argan Inc EC $39.7M 1.79%
Sitime Corp EC $38.5M 1.73%
Lattice Semiconductor Corp EC $38.1M 1.71%
Nova Ltd EC $35.6M 1.60%
10x Genomics Inc EC $34.6M 1.56%
Bel Fuse Inc EC $34.1M 1.54%
Sterling Infrastructure Inc EC $33.7M 1.52%
Modine Manufacturing Co EC $33.5M 1.51%
Madrigal Pharmaceuticals Inc EC $33.3M 1.50%
Mercury Systems Inc EC $33.1M 1.49%
Littelfuse Inc EC $32.9M 1.48%
Glaukos Corp EC $30.1M 1.36%
Comfort Systems Usa Inc EC $30M 1.35%
Fidelity Investments STIV $29.8M 1.34%
Construction Partners Inc EC $29.7M 1.34%
Legence Corp EC $29.6M 1.33%
Imax Corp EC $29.4M 1.32%
Mirum Pharmaceuticals Inc EC $29.2M 1.31%
Ptc Therapeutics Inc EC $29M 1.31%
Bridgebio Pharma Inc EC $28.5M 1.28%
Hut 8 Corp EC $27.8M 1.25%
Cardinal Infrastructure Group Inc EC $27.3M 1.23%
Moog Inc EC $27.2M 1.22%
Macom Technology Solutions Holdings Inc EC $27.2M 1.22%
Protagonist Therapeutics Inc EC $27.2M 1.22%
Semtech Corp EC $27M 1.21%
Adaptive Biotechnologies Corp EC $27M 1.21%
Cipher Digital Inc EC $26.6M 1.20%
Spx Technologies Inc EC $26.2M 1.18%
Nextpower Inc EC $25.5M 1.15%
Carpenter Technology Corp EC $25.1M 1.13%
Vita Coco Co Inc/the EC $24.9M 1.12%
Xometry Inc EC $24.8M 1.12%
Wisdomtree Inc EC $24.2M 1.09%
Vse Corp EC $24.1M 1.09%
Praxis Precision Medicines Inc EC $23.6M 1.06%
Definium Therapeutics Inc EC $23.4M 1.05%
Dianthus Therapeutics Inc EC $23.2M 1.04%
Rbc Bearings Inc EC $23.2M 1.04%
Pattern Group Inc EC $23.1M 1.04%
Tango Therapeutics Inc EC $23.1M 1.04%
Saia Inc EC $22.7M 1.02%
Oruka Therapeutics Inc EC $21.7M 0.98%
Universal Technical Institute Inc EC $21.7M 0.98%
Cg Oncology Inc EC $21.3M 0.96%
Arrowhead Pharmaceuticals Inc EC $21.1M 0.95%
Billiontoone Inc EC $21M 0.94%
Ascendis Pharma A/s EC $20.6M 0.93%
Sphere Entertainment Co EC $20.4M 0.92%
Extreme Networks Inc EC $20.4M 0.92%
Cognex Corp EC $20.2M 0.91%
Hinge Health Inc EC $20.2M 0.91%
Miami International Holdings Inc EC $20.1M 0.90%

Showing top 60 of 95 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support